Jason D. Roh's research while affiliated with Massachusetts General Hospital and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (27)
Background: Osimertinib is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) for non-small cell lung cancer (NSCLC) treatment. Osimertinib potently and selectively inhibits EGFR-T790M resistance mutations in patients with NSCLC harboring these mutations. Emerging evidence from clinical trials has identified po...
Background:
The human heart has limited capacity to generate new cardiomyocytes and this capacity declines with age. Because loss of cardiomyocytes may contribute to heart failure, it is crucial to explore stimuli of endogenous cardiac regeneration to favorably shift the balance between loss of cardiomyocytes and the birth of new cardiomyocytes in...
Acute and chronic animal models of exercise are commonly used in research. Acute exercise testing is used, often in combination with genetic, pharmacological, or other manipulations, to study the impact of these manipulations on the cardiovascular response to exercise and to detect impairments or improvements in cardiovascular function that may not...
Heart failure with preserved ejection fraction (HFpEF) represents one of the greatest challenges facing cardiovascular medicine today. Despite being the most common form of heart failure worldwide, there has been limited success in developing therapeutics for this syndrome. This is largely due to our incomplete understanding of the biology driving...
To gain insights into the mechanisms driving cardiovascular complications in COVID-19, we performed a case-control plasma proteomics study in COVID-19 patients. Our results identify the senescence-associated secretory phenotype, a marker of biological aging, as the dominant process associated with disease severity and cardiac involvement. FSTL3, an...
Objective
Arterial stiffness is a risk factor for cardiovascular disease, including heart failure with preserved ejection fraction. MGP (matrix Gla protein) is implicated in vascular calcification in animal models, and circulating levels of the uncarboxylated, inactive form of MGP (ucMGP) are associated with cardiovascular disease-related and all-c...
Introduction: Peripartum cardiomyopathy (PPCM) is a rare form of pregnancy-related heart failure associated with preeclampsia. Our understanding of their shared pathophysiology is limited as are treatment options.
Hypothesis: We hypothesized that plasma proteomic profiling would identify deleterious circulating proteins and provide insights into sh...
Cardiovascular complications are common in COVID-19 and strongly associated with disease severity and mortality. However, the mechanisms driving cardiac injury and failure in COVID-19 are largely unknown. We performed plasma proteomics on 80 COVID-19 patients and controls, grouped according to disease severity and cardiac involvement. Findings were...
Given the role of comorbid conditions in the pathophysiology of HFpEF, we aimed to identify and rank the importance of comorbid conditions associated with post-hospitalization outcomes of older adults hospitalized for HFpEF. We examined data from 4605 Medicare beneficiaries hospitalized in 2007-2014 for HFpEF based on ICD-9-CM codes for acute diast...
Background
Delivery of hydrogels to the heart is a promising strategy for mitigating the detrimental impact of myocardial infarction ( MI ). Challenges associated with the in vivo delivery of currently available hydrogels have limited clinical translation of this technology. Gelatin methacryloyl (Gel MA ) bioadhesive hydrogel could address many of...
Heart failure with preserved ejection fraction (HFpEF) is the most common type of HF in older adults. Although no pharmacological therapy has yet improved survival in HFpEF, exercise training (ExT) has emerged as the most effective intervention to improving functional outcomes in this age‐related disease. The molecular mechanisms by which ExT induc...
During aging, deterioration in cardiac structure and function leads to increased susceptibility to heart failure. The need for interventions to combat this age-related cardiac decline is becoming increasingly urgent as the elderly population continues to grow. Our understanding of cardiac aging, and aging in general, is limited. However, recent stu...
Activin type II receptor (ActRII) ligands have been implicated in muscle wasting in aging and disease. However, the role of these ligands and ActRII signaling in the heart remains unclear. Here, we investigated this catabolic pathway in human aging and heart failure (HF) using circulating follistatin-like 3 (FSTL3) as a potential indicator of syste...
Highlights
• Direct invasion from the pericardium is a known mechanism of cardiac tuberculosis.
• Tubercular granulomas may cause hemodynamically significant stenosis.
• Tubercular granulomas may regress completely with antitubercular therapy.
• TTE is key in detecting tuberculosis complications and monitoring treatment response.
Parasternal long-axis view demonstrates a loculated anterior pericardial effusion, mildly impaired left ventricular systolic function, and a septal bounce. A pericardial fluid biopsy grows pan-sensitive M tuberculosis.
Cardiac cine magnetic resonance imaging in the plane of the main pulmonary artery demonstrates a nonobstructive pulmonary artery mass just superior to the pulmonic annulus.
Follow-up TTE, before the completion of antitubercular therapy, reveals a fixed, spherical mass (arrow) projecting into the main pulmonary artery lumen. The anterior loculated pericardial effusion remains.
Color Doppler demonstrates laminar flow around the mass.
Cardiovascular disease constitutes the leading cause of mortality in patients with chronic kidney disease (CKD) and end-stage renal disease. Despite increasing recognition of a close interplay between kidney dysfunction and cardiovascular disease, termed cardiorenal syndrome (CRS), the underlying mechanisms of CRS remain poorly understood. Here we...
Sarco/endoplasmic reticulum Ca ²⁺ -ATPase 2a (SERCA2a) is a critical regulator of cardiac function whose expression is decreased in aging and heart failure (HF). Activin-A, a member of the TGFβ superfamily, has been shown to be a potent paracrine inhibitor of SERCA2a expression in cardiomyocytes (CM). However, the mechanism by which this occurs rem...
Macrophages populate the healthy myocardium and, depending on their phenotype, may contribute to tissue homeostasis or disease. Their origin and role in diastolic dysfunction, a hallmark of cardiac aging and heart failure with preserved ejection fraction, remain unclear. Here we show that cardiac macrophages expand in humans and mice with diastolic...
Interferon regulatory factor 3 (IRF3) and type I interferons (IFNs) protect against infections1 and cancer2, but excessive IRF3 activation and type I IFN production cause autoinflammatory conditions such as Aicardi–Goutières syndrome3,4 and STING-associated vasculopathy of infancy (SAVI)3. Myocardial infarction (MI) elicits inflammation5, but the d...
The lack of effective treatments for heart failure with preserved ejection fraction represents a large and growing unmet need in cardiology today. A critical obstacle to therapeutic innovation in heart failure with preserved ejection fraction has been the absence of animal models that accurately recapitulate the complexities of the human disease. H...
Aging induces structural and functional changes in the heart that are associated with increased risk of cardiovascular disease and impaired functional capacity in the elderly. Exercise is a diagnostic and therapeutic tool, with the potential to provide insights into clinical diagnosis and prognosis, as well as the molecular mechanisms by which agin...
Citations
... Physical activity promotes healthy aging and prevents CVD [162][163][164][165] . Progressive and vigorous exercise for 1 year in previously sedentary people aged 65 and over induces physiological LV remodeling, increases stroke volume and total aortic compliance, and decreases arterial elastance [166] , while studies in aged mice correlated the benefits of exercise with increased exercise capacity, improved diastolic function, physiological cardiac hypertrophy and increased cardiomyogenesis [167][168][169] . Even in mice expressing a proofreading-deficient version of Polg, endurance exercise for 5 months increases mitochondrial biogenesis and mitochondrial oxidative capacity and alleviates age-associated cardiomyopathy [170] . ...
... Human walking and running activities may be modeled in rodents through experimental paradigms based on exposure to different kinds of voluntary and involuntary exercise, that can be scheduled to construct an acute or chronic model [74]. The exposure to voluntary aerobic activity is typically carried out by means of running wheels or an equivalent tool, such as an angled rotating running track [21]. ...
... With a rapid increase in its incidence and prevalence, heart failure (HF) is a major public health issue. 1 Currently, HF with preserved left ventricular ejection fraction (HFpEF) has been recognized as the major form of HF, with a 5-year survival rate after the first hospitalization of 35%-40%. 1 HFpEF is a systemic syndrome characterized by diastolic dysfunction, classic HF symptomatology (shortness of breath, edema, and exercise intolerance), and a normal left ventricular ejection fraction (LVEF, >50%), involving heart, liver, skeleton muscle, adipose, and other tissue. 2 Increasing evidence recognized the essential role of inflammation in the development of HFpEF, as demonstrated by elevated levels of plasma biomarkers (to name a few, C reactive proteins [CRP], tumor necrotic factor alpha [TNF-α], and pentraxin 3 [PTX3]) and improved performance postantiinflammatory interventions. 2 As an important but generally overlooked subgroup of white blood cells, eosinophil was considered as an antiparasitic and pro-allergic player due to its capacity to produce galectin-10, major basic protein (MBP), eosinophil cationic protein (ECP), eosinophil peroxidase (EPO), derivatives of arachidonic acid, and other active substances. ...
... Multiple factors likely contribute to cardiac injury and dysfunction in COVID-19 [9]. It seems that the occurrence of COVID-19-induced myocardial damage is a multifaceted pathophysiological process that includes interplay between oxidative distress, inflammation, endothelial dysfunction and thrombosis as the major underlying mechanisms [10][11][12]. ...
... These particles transport calcium and phosphate to bones and prevent vascular calcification by inhibiting growth and aggregation of hydroxyapatite (Jahnen-Dechent et al., 2011). MGP deficiency upregulates the expression of runt-related transcription factor 2 (Runx2), which promotes transdifferentiation of vascular smooth muscle cells (VSMCs) into osteochondrogenic cells (Malhotra et al., 2022). These transdifferentiated VSMCs secrete calcium ions and phosphate ions, accelerating vascular calcification (Speer et al., 2009;Neven et al., 2011). ...
... In contrast, proinflammatory pathways of IL6, IL1, and TNFA signaling were not increased in Ad26.COV2.S vaccinated macaques (Fig 4B). Further, proteomics analysis showed that pathways of thrombosis and markers upregulated in plasma from severe COVID-19 patients [26] were upregulated in sham macaques challenged with WA1/2020 or B.1.351 variant but were unchanged in vaccinated animals (Fig 4B). ...
... In this study, it was different from the previous studies that the prevelance of frailty in HFpEF is the lowest among the three categories of HF. A previous study has shown that HF patients with HFpEF are more likely to have frailty and higher frailty states [36]. Compared with the previous studies, the age of participants in this study is relatively low (73 [68e80]), which may be the possible reason for the difference between this study and previous studies. ...
... Other studies have reported hydrogel scaffolds prepared from various biocompatible polymeric materials that included N-isopropylacrylamide (NIPAAm), poly Nisopropylacrylamide (PNIPAAm), 2-hydroxyethyl methacrylate (HEMA), methacrylate polylactide (MAPLA), dextran (Dex), poly(ε-caprolactone) (PCL) and gelatine [79][80][81]. Poly (NIPAAm-co-HEMA-co-MAPLA) hydrogels [79] in an infarcted swine model, whereas Dex-PCL-HEMA/PNIPAAm (DPHP) hydrogels [80] and gelatine methacryloyl hydrogels [81] in infarcted rodents have also been shown to attenuate LV remodelling and improve cardiac function. ...
... Several potential mechanisms might underlie the observed relations between a healthy lifestyle and HF. Animal studies have shown that exercise training (ExT) can reverse cardiac aging phenotypes associated with heart failure with preserved ejection fraction (HfpEF) in male mice, and its molecular mechanism involves that ExT reversing the downregulation of fatty acid metabolism pathways related to aging and ultimately regulating the cell cycle and cell division [49]. Other animal studies in mice have also shown that the improvement of heart failure by exercise is related to the recovery of oxidative metabolism [50], the β3-AR-nNOS-NO pathway [51], autonomic imbalance, and impaired calcium homeostasis [52]. ...
... 3 Apart from age being an irreversible signi cant risk factor, other geriatric factors such as multimorbidity, polypharmacy, cognitive impairment and frailty can make HF management in older people complex. 1,4 With the growing population of older people and how the prevalence of HF doubles with each decade, managing HF in older people continues to be one of the major challenges in cardiovascular care. 5 The major goals of therapy in HF management include improving quality of life, reducing mortality risk and preventing hospital readmission. ...